Bayer Aktiengesellschaft (BAYRY)
OTCMKTS · Delayed Price · Currency is USD
8.29
+0.22 (2.73%)
Sep 30, 2025, 3:58 PM EDT
Bayer Aktiengesellschaft Employees
Bayer Aktiengesellschaft had 91,864 employees as of December 31, 2024. The number of employees decreased by 5,067 or -5.23% compared to the previous year.
Employees
91,864
Change (1Y)
-5,067
Growth (1Y)
-5.23%
Revenue / Employee
$605,506
Profits / Employee
-$44,822
Market Cap
32.54B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 91,864 | -5,067 | -5.23% |
Dec 31, 2023 | 96,931 | -991 | -1.01% |
Dec 31, 2022 | 97,922 | 1,972 | 2.06% |
Dec 31, 2021 | 95,950 | -5 | -0.01% |
Dec 31, 2020 | 95,955 | -2,782 | -2.82% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Elite Pharmaceuticals | 68 |
Tian'an Technology Group | 8 |
Glass House Brands | 374 |
Northwest Biotherapeutics | 25 |
CytoDyn | 13 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
Jushi Holdings | 1,234 |
Bayer Aktiengesellschaft News
- 5 days ago - Bayer Canada Announces New Distribution Partnership for ADALAT® XL® (nifedipine extended-release tablets) 30 mg Tablets in Canada - Business Wire
- 5 days ago - Bayer to Highlight New Data for KERENDIA® (finerenone) at Heart Failure Society of America (HFSA) Annual Scientific Meeting 2025 - Business Wire
- 5 days ago - Focus: Parkinson's disease at forefront of Bayer bet on cell and gene therapies - Reuters
- 7 days ago - Shilpa Medicare shares jump over 4% as EMA grants nod for Rivaroxaban Orodispersible Films - Business Upturn
- 8 days ago - Bayer CEO: overhaul is leading to pharma pipeline boost - Reuters
- 8 days ago - Bayer moves Parkinson's cell therapy into Phase III trial - Reuters
- 8 days ago - Bayer First Company to Advance Cell Therapy as Well as Gene Therapy Against Parkinson's Disease - Business Wire
- 12 days ago - Irelands pharma sector is world class, but why dont we have a Novo Nordisk to take our success to the next level? - Independent Ireland